The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients: Mitoquinone and liver damage

Edward J. Gane, Frank Weilert, David W. Orr, Geraldine F. Keogh, Michael Gibson, Michelle M. Lockhart, Christopher M. Frampton, Kenneth M. Taylor, Robin A. J. Smith and Michael P. Murphy

Liver Int. 30, 1019–26 (2010). DOI: 10.1111/j.1478-3231.2010.02250.x


Leave a Reply

Your email address will not be published. Required fields are marked *